RASSF1 and ovarian cancer: Giannopoulou et al. evaluated hypermethylation of RASSF1A in plasma and tissue samples collected from 53 patients with high-grade serous ovarian cancer, using real-time MSP with 62.3% of plasma samples showing a correspondence in RASSF1A methylation to matched ovarian cancer tissue [81].